EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Transatlantic differences in the use and outcome of minimally invasive pancreatoduodenectomy: an international multi-registry analysis

Nine de Graaf iD, Simone Augustinus, Ulrich F Wellner, Karin Johansen, Bodil Andersson, Joal D Beane, Bergthor Björnsson, Olivier R Busch, Catherine H Davis, Michael Ghadimi, Elizabeth M Gleeson, Bas Groot Koerkamp und 13 weitere

Surgical Endoscopy · 2024

DOI: 10.1007/s00464-024-11161-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Surgical Endoscopy, 2024. Verfasst von Nine de Graaf und 24 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Registries, Laparoscopy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Minimally invasive pancreatoduodenectomy (MIPD) has emerged as an alternative to open pancreatoduodenectomy (OPD). However, the extent of variation in the use and outcomes of MIPD in relation to OPD among countries is unclear as international studies using registry data are lacking. This study aimed to investigate the use, patient selection, and outcomes of MIPD and OPD in four transatlantic audits for pancreatic surgery.

Methods

A post hoc comparative analysis including consecutive patients after MIPD and OPD from four nationwide and multicenter pancreatic surgery audits from North America, Germany, the Netherlands, and Sweden (2014–2020). Patient factors related to MIPD were identified using multivariable logistic regression. Outcome analyses excluded the Swedish audit because < 100 MIPD were performed during the studied period.

Results

Overall, 44,076 patients who underwent pancreatoduodenectomy were included (29,107 North America, 7586 Germany, 4970 the Netherlands, and 2413 Sweden), including 3328 MIPD procedures (8%). The use of MIPD varied widely among countries (absolute largest difference [ALD] 17%, p < 0.001): 7% North America, 4% Germany, 17% the Netherlands, and 0.1% Sweden. Over time, the use of MIPD increased in North America and the Netherlands ( p < 0.001), mostly driven by robotic MIPD, but not in Germany ( p = 0.297). Patient factors predicting the use of MIPD included country, later year of operation, better performance status, high POPF-risk score, no vascular resection, and non-malignant indication. Conversion rates were higher in laparoscopic MIPD (range 28–45%), compared to robotic MIPD (range 9–37%). In-hospital/30-day mortality differed among North America, Germany, and the Netherlands; MIPD (2%, 7%, 4%; ALD 5%, p < 0.001) and OPD (2%, 5%, 3%; ALD 3%, p < 0.001), similar to major morbidity; MIPD (25%, 42%, 38%, ALD 17%, p < 0.001) and OPD (25%, 31%, 30%, ALD 6%, p < 0.001), respectively.

Conclusions

Considerable differences were found in the use and outcome, including conversion and mortality rates, of MIPD and OPD among four transatlantic audits for pancreatic surgery. Our findings highlight the need for international collaboration to optimize treatment standards and patient outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreaticoduodenectomyRegistriesLaparoscopyHumansMaleFemaleMiddle AgedAgedSwedenNorth AmericaRobotic Surgical ProceduresNetherlandsPostoperative ComplicationsPatient SelectionTreatment OutcomeGermany

Stichwörter der Autor:innen

LaparoscopyMinimally invasive surgeryPancreatic cancerRobot-assistedRoboticWhipplepancreatoduodenectomy

Autor:innen und Institutionen

  • Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Fondazione Poliabulanza Istituto Ospedaliero, Brescia, Italy.
  • Department of Surgery Amsterdam, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • DGAV StuDoQ|Pancreas and Clinic of Surgery, UKSH Campus Lübeck, Lübeck, Germany.
  • Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Department of Clinical Sciences Lund, Surgery, Lund University and Skåne University Hospital, Lund, Sweden.

ORCID-Profile: Nine de Graaf

Zitieren

APA

de Graaf, N., Augustinus, S., Wellner, U. F., Johansen, K., Andersson, B., Beane, J. D., Björnsson, B., Busch, O. R., Davis, C. H., Ghadimi, M., Gleeson, E. M., Groot Koerkamp, B., Hogg, M. E., van Santvoort, H. C., Tingstedt, B., Uhl, W., Werner, J., Williamsson, C., Zeh, H. J., …, & Global Audits on Pancreatic Surgery Group (GAPASURG) (2024). Transatlantic differences in the use and outcome of minimally invasive pancreatoduodenectomy: an international multi-registry analysis. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-11161-7

Vancouver

de Graaf N, Augustinus S, Wellner UF, Johansen K, Andersson B, Beane JD, et al. Transatlantic differences in the use and outcome of minimally invasive pancreatoduodenectomy: an international multi-registry analysis. Surgical Endoscopy. 2024. doi:10.1007/s00464-024-11161-7

BibTeX
@article{deGraaf2024,
  author = {de Graaf, Nine and Augustinus, Simone and Wellner, Ulrich F and Johansen, Karin and Andersson, Bodil and Beane, Joal D and Björnsson, Bergthor and Busch, Olivier R and Davis, Catherine H and Ghadimi, Michael and Gleeson, Elizabeth M and Groot Koerkamp, Bas and Hogg, Melissa E and van Santvoort, Hjalmar C and Tingstedt, Bobby and Uhl, Waldemar and Werner, Jens and Williamsson, Caroline and Zeh, Herbert J and Zureikat, Amer H and Abu Hilal, Mohammad and Pitt, Henry A and Besselink, Marc G and Keck, Tobias and Global Audits on Pancreatic Surgery Group (GAPASURG), Global Audits on Pancreatic Surgery Group (GAPASURG)},
  title = {Transatlantic differences in the use and outcome of minimally invasive pancreatoduodenectomy: an international multi-registry analysis},
  journal = {Surgical Endoscopy},
  year = {2024},
  doi = {10.1007/s00464-024-11161-7}
}
Kostenlos starten →